Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > STTK Shattuck Labs > Detailed Quotes

STTK Shattuck Labs

2.700
-0.060-2.17%
Close 09/30 16:00 ET
2.590
-0.110-4.07%
Post Mkt Price 09/30 17:04 ET
High
2.870
Open
2.750
Turnover
930.62K
Low
2.630
Pre Close
2.760
Volume
342.60K
Market Cap
114.43M
P/E(TTM)
Loss
52wk High
20.950
Shares
42.38M
P/E(Static)
Loss
52wk Low
2.550
Float Cap
75.60M
Bid/Ask %
0.00%
Historical High
60.516
Shs Float
28.00M
Volume Ratio
5.22
Historical Low
2.550
Dividend TTM
--
Div Yield TTM
--
P/B
0.51
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
1.22%
Amplitude
8.70%
Avg Price
2.716
Lot Size
1
Float Cap
75.60M
Bid/Ask %
0.00%
Historical High
60.516
Shs Float
28.00M
Volume Ratio
5.22
Historical Low
2.550
Dividend TTM
--
P/B
0.51
Dividend LFY
--
Turnover Ratio
1.22%
Amplitude
8.70%
Avg Price
2.716
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Shattuck Labs, Inc. engages in the research and development of dual-sided fusion proteins used for medical treatment of cancer and autoimmune disease. It primarily focuses on Agonist Redirected Checkpoint (ARC) and Gamma Delta T Cell Engagers (GADLEN) platforms. It develops a novel class of biologic medicines, capable of multifunctional activity, with potential applications in oncology and autoimmune diseases. The company was founded by Josiah C. Hornblower and Taylor Schreiber in 2016 and is headquartered in Austin, TX.
CEO: Dr. Taylor H. Schreiber, M.D.,PhD
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...